446 related articles for article (PubMed ID: 9521743)
1. Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands.
Szegletes T; Mallender WD; Rosenberry TL
Biochemistry; 1998 Mar; 37(12):4206-16. PubMed ID: 9521743
[TBL] [Abstract][Full Text] [Related]
2. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect.
Szegletes T; Mallender WD; Thomas PJ; Rosenberry TL
Biochemistry; 1999 Jan; 38(1):122-33. PubMed ID: 9890890
[TBL] [Abstract][Full Text] [Related]
3. Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate.
Johnson JL; Cusack B; Davies MP; Fauq A; Rosenberry TL
Biochemistry; 2003 May; 42(18):5438-52. PubMed ID: 12731886
[TBL] [Abstract][Full Text] [Related]
4. Binding of the neurotoxin fasciculin 2 to the acetylcholinesterase peripheral site drastically reduces the association and dissociation rate constants for N-methylacridinium binding to the active site.
Rosenberry TL; Rabl CR; Neumann E
Biochemistry; 1996 Jan; 35(3):685-90. PubMed ID: 8547248
[TBL] [Abstract][Full Text] [Related]
5. A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate.
Rosenberry TL; Mallender WD; Thomas PJ; Szegletes T
Chem Biol Interact; 1999 May; 119-120():85-97. PubMed ID: 10421442
[TBL] [Abstract][Full Text] [Related]
6. Interactions between the peripheral site and the acylation site in acetylcholinesterase.
Rosenberry TL; Johnson JL; Cusack B; Thomas JL; Emani S; Venkatasubban KS
Chem Biol Interact; 2005 Dec; 157-158():181-9. PubMed ID: 16256966
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholinesterase complexed with bivalent ligands related to huperzine a: experimental evidence for species-dependent protein-ligand complementarity.
Wong DM; Greenblatt HM; Dvir H; Carlier PR; Han YF; Pang YP; Silman I; Sussman JL
J Am Chem Soc; 2003 Jan; 125(2):363-73. PubMed ID: 12517147
[TBL] [Abstract][Full Text] [Related]
8. Fasciculin 2 binds to the peripheral site on acetylcholinesterase and inhibits substrate hydrolysis by slowing a step involving proton transfer during enzyme acylation.
Eastman J; Wilson EJ; Cerveñansky C; Rosenberry TL
J Biol Chem; 1995 Aug; 270(34):19694-701. PubMed ID: 7649979
[TBL] [Abstract][Full Text] [Related]
9. Acetylthiocholine binds to asp74 at the peripheral site of human acetylcholinesterase as the first step in the catalytic pathway.
Mallender WD; Szegletes T; Rosenberry TL
Biochemistry; 2000 Jul; 39(26):7753-63. PubMed ID: 10869180
[TBL] [Abstract][Full Text] [Related]
10. Role of the peripheral anionic site on acetylcholinesterase: inhibition by substrates and coumarin derivatives.
Radić Z; Reiner E; Taylor P
Mol Pharmacol; 1991 Jan; 39(1):98-104. PubMed ID: 1987454
[TBL] [Abstract][Full Text] [Related]
11. Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase.
Berman HA; Leonard K
Mol Pharmacol; 1992 Feb; 41(2):412-8. PubMed ID: 1538717
[TBL] [Abstract][Full Text] [Related]
12. Thioflavin T is a fluorescent probe of the acetylcholinesterase peripheral site that reveals conformational interactions between the peripheral and acylation sites.
De Ferrari GV; Mallender WD; Inestrosa NC; Rosenberry TL
J Biol Chem; 2001 Jun; 276(26):23282-7. PubMed ID: 11313335
[TBL] [Abstract][Full Text] [Related]
13. Organophosphorylation of acetylcholinesterase in the presence of peripheral site ligands. Distinct effects of propidium and fasciculin.
Mallender WD; Szegletes T; Rosenberry TL
J Biol Chem; 1999 Mar; 274(13):8491-9. PubMed ID: 10085081
[TBL] [Abstract][Full Text] [Related]
14. Heterocyclic inhibitors of AChE acylation and peripheral sites.
Bolognesi ML; Andrisano V; Bartolini M; Cavalli A; Minarini A; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
Farmaco; 2005; 60(6-7):465-73. PubMed ID: 15878569
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of "peripheral" site ligands on Torpedo and chicken acetylcholinesterase.
Eichler J; Anselment A; Sussman JL; Massoulié J; Silman I
Mol Pharmacol; 1994 Feb; 45(2):335-40. PubMed ID: 8114681
[TBL] [Abstract][Full Text] [Related]
16. Allosteric control of acetylcholinesterase activity by monoclonal antibodies.
Saxena A; Hur R; Doctor BP
Biochemistry; 1998 Jan; 37(1):145-54. PubMed ID: 9425034
[TBL] [Abstract][Full Text] [Related]
17. [The fasciculin-acetylcholinesterase interaction].
Marchot P
J Soc Biol; 1999; 193(6):505-8. PubMed ID: 10783708
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of inhibition of substrate hydrolysis by a ligand bound to the peripheral site of acetylcholinesterase.
Auletta JT; Johnson JL; Rosenberry TL
Chem Biol Interact; 2010 Sep; 187(1-3):135-41. PubMed ID: 20493829
[TBL] [Abstract][Full Text] [Related]
19. Conformers of acetylcholinesterase: a mechanism of allosteric control.
Taylor JL; Mayer RT; Himel CM
Mol Pharmacol; 1994 Jan; 45(1):74-83. PubMed ID: 8302283
[TBL] [Abstract][Full Text] [Related]
20. Kinetic model of ethopropazine interaction with horse serum butyrylcholinesterase and its docking into the active site.
Golicnik M; Sinko G; Simeon-Rudolf V; Grubic Z; Stojan J
Arch Biochem Biophys; 2002 Feb; 398(1):23-31. PubMed ID: 11811945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
